Cargando…
Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China
BACKGROUND: CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) is a rare subtype of DLBCL with invasive clinical features and poor prognosis. Current clinical variables based on prognostic systems for DLBCL are inadequate to accurately stratify the prognosis of CD5+ DLBCL. METHODS: A total of 1...
Autores principales: | Shen, Ziyuan, Wang, Ling, Zhang, Bingpei, Li, Tianci, Li, Dashan, He, Chenlu, Xue, Yuhao, Wang, Ying, Li, Bingzong, Liu, Qinhua, Zhang, Hao, Gu, Weiying, Wang, Fei, Wang, Chunling, Shi, Yuye, Ye, Jingjing, Zhu, Taigang, Miao, Yuqing, Huang, Shuiping, Sang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595286/ https://www.ncbi.nlm.nih.gov/pubmed/34804942 http://dx.doi.org/10.3389/fonc.2021.754180 |
Ejemplares similares
-
The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis
por: Shen, Ziyuan, et al.
Publicado: (2021) -
The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
por: Shen, Ziyuan, et al.
Publicado: (2022) -
A Novel Prognostic Index Model for Adult Hemophagocytic Lymphohistiocytosis: A Multicenter Retrospective Analysis in China
por: Shen, Ziyuan, et al.
Publicado: (2022) -
LASSO Model Better Predicted the Prognosis of DLBCL than Random Forest Model: A Retrospective Multicenter Analysis of HHLWG
por: Shen, Ziyuan, et al.
Publicado: (2022) -
Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma
por: Sang, Wei, et al.
Publicado: (2022)